Cage Pharmaceuticals, Inc.

New Filing
CIK: 0001727073·Other Health Care·DELAWARE·Filed: May 31, 2024
Total Offering

$137,490

Amount Sold

$137,490

Investors

2

First Sale

May 1, 2024

Offering Details

Type
Equity
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Peter Olagunju
Related Person
Isaac Ro
Related Person
Brian Malik
Related Person
Nick Papadopoulos
Related Person

Company

Cage Pharmaceuticals, Inc.

512 W. 22nd Street

New York, NY, 10011

917-832-1832

SEC Filing

0001727073-24-000001

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Cage Pharmaceuticals, Inc. Form D Filing — $137,490 | FilingFlow